1. Home
  2. CTKB vs BIOA Comparison

CTKB vs BIOA Comparison

Compare CTKB & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.25

Market Cap

595.2M

Sector

Health Care

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$17.20

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
BIOA
Founded
1990
2015
Country
United States
United States
Employees
N/A
62
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.2M
681.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
BIOA
Price
$4.25
$17.20
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$5.63
$51.50
AVG Volume (30 Days)
976.1K
388.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,015,000.00
N/A
Revenue This Year
$5.42
$720.93
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.67
N/A
52 Week Low
$2.62
$3.93
52 Week High
$6.18
$24.00

Technical Indicators

Market Signals
Indicator
CTKB
BIOA
Relative Strength Index (RSI) 53.28 50.04
Support Level $4.13 $15.49
Resistance Level $4.29 $19.01
Average True Range (ATR) 0.27 1.17
MACD 0.05 0.01
Stochastic Oscillator 73.55 54.57

Price Performance

Historical Comparison
CTKB
BIOA

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: